APA (7th ed.) Citation

MM, O., AB, I., R, A., SA, S., & MS, H. (2024). Imatinib pharmacokinetics and creatine kinase levels in chronic myeloid leukemia patients: Implications for therapeutic response and monitoring. European journal of clinical pharmacology, 80(7), 1061. https://doi.org/10.1007/s00228-024-03675-9

Chicago Style (17th ed.) Citation

MM, Omran, Ibrahim AB, Abdelfattah R, Shouman SA, and Hamza MS. "Imatinib Pharmacokinetics and Creatine Kinase Levels in Chronic Myeloid Leukemia Patients: Implications for Therapeutic Response and Monitoring." European Journal of Clinical Pharmacology 80, no. 7 (2024): 1061. https://doi.org/10.1007/s00228-024-03675-9.

MLA (9th ed.) Citation

MM, Omran, et al. "Imatinib Pharmacokinetics and Creatine Kinase Levels in Chronic Myeloid Leukemia Patients: Implications for Therapeutic Response and Monitoring." European Journal of Clinical Pharmacology, vol. 80, no. 7, 2024, p. 1061, https://doi.org/10.1007/s00228-024-03675-9.